Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening to Include Severe Combined Immune Deficiency (SCID) (U01)

The summary for the Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening to Include Severe Combined Immune Deficiency (SCID) (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.

Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening to Include Severe Combined Immune Deficiency (SCID) (U01): CDCs Procurement and Grants Office has published a funding opportunity announcement entitled, "Program to Expand State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening to Include Severe Combined Immune Deficiency (SCID) (U01)." Approximately $1,000,000 will be available in fiscal year 2008 to fund 2 awards. The purpose of the program is to conduct research to develop and evaluate newborn bloodspot screening tests for forms of Severe Combined Immune Deficiency Disease (SCID). Newborn bloodspot screening (NBS) is a vital public health program that tests babies for congenital disorders which are not apparent at birth. For complete program details, please see the full announcement on the CDC website at http://www.cdc.gov/od/pgo/funding/EH08-002.htm. The estimated funding date is August 31, 2008.